Volume 13, Number 4—April 2007
Endpoints for Lymphatic Filariasis Programs
*Based on tally counts from distribution posts.
†Using 108,000 as the total population of Leogane determined by cluster survey in 2000, adjusted for annual population growth.
International Data Base (IDB): available from http://www.census.gov/ipc/www/idbprint.html
‡Published data (7,8)
§Based on the number of persons who reported to distribution posts with reportts adverse events as a percentage of the reported coverage. See reference (9) for a more detailed discussion of adverse events associated with the first round of mass drug administration..